Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neurologic Stem Cell Treatment Study
- Development stage
- Unknown
- Lead developer
- MD Stem Cells
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intranasal
01
Overview
The Neurologic Stem Cell Treatment Study (NEST) is an autologous cell therapy protocol developed by MD Stem Cells that utilizes bone marrow-derived stem cells (BMSCs) for the treatment of various neurological disorders and injuries. The procedure involves harvesting the patient's own bone marrow, isolating the stem cells, and administering them through a dual-delivery approach: intravenously and intranasally. The intranasal delivery specifically targets the lower third of the nasal passages to facilitate entry into the central nervous system, potentially bypassing the blood-brain barrier. This therapy is intended to promote neuroregeneration and tissue repair across a broad spectrum of conditions, including neurodegenerative diseases like Parkinson's and Alzheimer's, as well as traumatic injuries. NEST is currently being evaluated in a Phase 2 clinical trial.
- Other names
- NEST StudyNeurologic Stem Cell Treatment
Beyond the preview
Go deeper on Neurologic Stem Cell Treatment Study.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neurologic Stem Cell Treatment Study.